---
title: "DC 7627 - Malignant neoplasms of gynecological system"
diagnostic_code: "7627"
body_system: "Gynecological Conditions and Disorders of the Breast"
cfr_section: "§ 4.116"
canonical: "https://veteranai.co/va-rating-schedule/gynecological/7627-malignant-neoplasms-of-gynecological-system"
source: "https://www.ecfr.gov/current/title-38/section-4.116"
updated: "2026-07-21T17:57:54.489677Z"
---

# DC 7627 - Malignant neoplasms of gynecological system

Rated under § 4.116. Body system: Gynecological Conditions and Disorders of the Breast.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Malignant neoplasms of gynecological system |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system

# Malignant Neoplasms of the Gynecological System (VA Diagnostic Code 7627)

**Body System:** Gynecological Conditions and Disorders of the Breast
**Regulation:** 38 CFR § 4.116

---

## Understanding This Condition

Diagnostic Code **7627** covers **malignant neoplasms of the gynecological system** — cancers affecting the gynecological organs. The VA rates this condition under § 4.116, the section of the rating schedule dedicated to gynecological conditions and disorders of the breast.

## Available Rating Level

Under this diagnostic code, the VA provides a single scheduled rating:

| Rating | Criteria |
|--------|----------|
| **100%** | Malignant neoplasms of the gynecological system |

## What the VA Looks For

The VA applies a **100 percent rating** for a malignant neoplasm of the gynecological system. Key points about how this rating works:

- **The 100% rating continues beyond active treatment.** It shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy, or other therapeutic procedures.

- **A mandatory examination follows treatment.** Six months after discontinuance of such treatment, the appropriate disability rating is determined by a **mandatory VA examination**.

- **Changes in evaluation follow due-process rules.** Any change in evaluation based upon that examination — or any subsequent examination — is subject to the provisions of § 3.105(e).

- **Chronic residuals are rated separately.** Ongoing effects such as **scars, lymphedema, disfigurement, and/or other impairment of function** are rated under the appropriate diagnostic code(s) within the appropriate body system.

---

*This information is drawn directly from the VA rating schedule (38 CFR § 4.116, Diagnostic Code 7627) and is provided for general educational purposes. Individual ratings depend on the specifics of your case and VA examination findings.*

Source: https://www.ecfr.gov/current/title-38/section-4.116